These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

103 related articles for article (PubMed ID: 22951795)

  • 1. [Antidepressants in the treatment of alcoholism].
    Sivolap IuP
    Zh Nevrol Psikhiatr Im S S Korsakova; 2012; 112(5 Pt 2):32-5. PubMed ID: 22951795
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Evaluation of the prophylactic efficacy of amitriptyline and citalopram, alone or in combination, in patients with comorbidity of depression, migraine, and tension-type headache.
    Rampello L; Alvano A; Chiechio S; Malaguarnera M; Raffaele R; Vecchio I; Nicoletti F
    Neuropsychobiology; 2004; 50(4):322-8. PubMed ID: 15539864
    [TBL] [Abstract][Full Text] [Related]  

  • 3. A randomized trial of combined citalopram and naltrexone for nonabstinent outpatients with co-occurring alcohol dependence and major depression.
    Adamson SJ; Sellman JD; Foulds JA; Frampton CM; Deering D; Dunn A; Berks J; Nixon L; Cape G
    J Clin Psychopharmacol; 2015 Apr; 35(2):143-9. PubMed ID: 25679122
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Escitalopram for the treatment of major depression and anxiety disorders.
    Höschl C; Svestka J
    Expert Rev Neurother; 2008 Apr; 8(4):537-52. PubMed ID: 18416657
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Serotonin transporter polymorphism as a predictor for escitalopram treatment of major depressive disorder comorbid with alcohol dependence.
    Muhonen LH; Lahti J; Alho H; Lönnqvist J; Haukka J; Saarikoski ST
    Psychiatry Res; 2011 Mar; 186(1):53-7. PubMed ID: 20800901
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Comorbid alcohol and substance abuse dependence in depression: impact on the outcome of antidepressant treatment.
    Ostacher MJ
    Psychiatr Clin North Am; 2007 Mar; 30(1):69-76. PubMed ID: 17362804
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Serum levels of brain-derived neurotrophic factor in comorbidity of depression and alcohol dependence.
    Umene-Nakano W; Yoshimura R; Ikenouchi-Sugita A; Hori H; Hayashi K; Ueda N; Nakamura J
    Hum Psychopharmacol; 2009 Jul; 24(5):409-13. PubMed ID: 19548207
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [Treatment of depression in patients with epilepsy].
    Bosak M; Dudek D; Siwek M
    Przegl Lek; 2013; 70(7):454-7. PubMed ID: 24167947
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [Nosologic comorbidity in addictive medicine].
    Eryshev OF
    Zh Nevrol Psikhiatr Im S S Korsakova; 2007; Suppl 1():21-5. PubMed ID: 18924466
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [Diagnostic indicators of comorbid alcohol and mood disorders].
    Burdjalieva AD
    Zh Nevrol Psikhiatr Im S S Korsakova; 2016; 116(11. Vyp. 2):58-60. PubMed ID: 28300815
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [Dual diagnosis: depression and alcohol use disorder].
    Sivolap YP; Krupitsky EM; Mendelevich VD; Rybakova KV; Vinnikova MA; Egorov AY; Usov GM
    Zh Nevrol Psikhiatr Im S S Korsakova; 2021; 121(7):135-140. PubMed ID: 34460170
    [TBL] [Abstract][Full Text] [Related]  

  • 12. The pharmacological treatment of alcohol dependence.
    Swift RM
    Med Health R I; 1997 Mar; 80(3):91-3. PubMed ID: 9117944
    [No Abstract]   [Full Text] [Related]  

  • 13. Antiplatelet effects of antidepressant treatment: a randomized comparison between escitalopram and nortriptyline.
    Flöck A; Zobel A; Bauriedel G; Tuleta I; Hammerstingl C; Höfels S; Schuhmacher A; Maier W; Nickenig G; Skowasch D
    Thromb Res; 2010 Aug; 126(2):e83-7. PubMed ID: 20553948
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Antidepressants for major depressive disorder and dysthymic disorder in patients with comorbid alcohol use disorders: a meta-analysis of placebo-controlled randomized trials.
    Iovieno N; Tedeschini E; Bentley KH; Evins AE; Papakostas GI
    J Clin Psychiatry; 2011 Aug; 72(8):1144-51. PubMed ID: 21536001
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [Clinical efficacy of escitalopram in patients with ischemic heart disease and comorbid depression].
    Pogosova GV; Koltunov IE; Karpova AV; Eliseeva NA; Sapunova ID
    Kardiologiia; 2009; 49(3):4-8. PubMed ID: 19257858
    [No Abstract]   [Full Text] [Related]  

  • 16. Citalopram dose-response revisited using an alternative psychometric approach to evaluate clinical effects of four fixed citalopram doses compared to placebo in patients with major depression.
    Bech P; Tanghøj P; Andersen HF; Overø K
    Psychopharmacology (Berl); 2002 Aug; 163(1):20-5. PubMed ID: 12185396
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Duloxetine versus citalopram and sertraline in the treatment of poststroke depression, anxiety, and fatigue.
    Karaiskos D; Tzavellas E; Spengos K; Vassilopoulou S; Paparrigopoulos T
    J Neuropsychiatry Clin Neurosci; 2012; 24(3):349-53. PubMed ID: 23037649
    [TBL] [Abstract][Full Text] [Related]  

  • 18. The effect of escitalopram on platelet activity.
    Canan F; Ataoglu A
    Thromb Res; 2011 Jan; 127(1):57. PubMed ID: 20709365
    [No Abstract]   [Full Text] [Related]  

  • 19. Escitalopram/reboxetine combination in depressed patients with substance use disorder.
    Camarasa X; Lopez-Martinez E; Duboc A; Khazaal Y; Zullino DF
    Prog Neuropsychopharmacol Biol Psychiatry; 2005 Jan; 29(1):165-8. PubMed ID: 15610962
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Ambulatory management in alcoholism.
    Bort RF
    Am Fam Physician; 1977 Nov; 16(5):131-4. PubMed ID: 21561
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.